Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

PropertyValue
has major subject area list Enzyme Inhibitors; Indoles; Lung Diseases, Interstitial; Protein-Tyrosine Kinases; Scleroderma, Systemic
information resource reference Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. N Engl J Med. 2019 06 27; 380(26):2518-2528.
label Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

Search Criteria
  • Scleroderma Systemic

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)